Skip to main content
. 2022 Jan 26;10(2):265. doi: 10.3390/biomedicines10020265

Figure 1.

Figure 1

Presentation of the early occlusion-like syndrome in isoprenaline (75 mg/kg sc) treated rats at 30 min after isoprenaline administration. Medication (BPC 157 (10 ng/kg (b), 10 µg/kg (B) i.p. or saline 5.0 mL/kg (C) i.p.) was given 5 min after isoprenaline. Heart, lung, liver and kidney lesions microscopic scoring (a); gastrointestinal lesion microscopic scoring (b); brain lesion microscopic scoring (c); blood (superior sagittal sinus (SSS), portal vein (PV), inferior caval vein (ICV), abdominal aorta (AA)) pressure (d); thrombus mass (portal vein (PV), inferior caval vein (ICV), superior sagittal sinus (SSS), abdominal aorta (AA) and superior mesenteric artery (SMA)) (e); and vessels (inferior caval vein (ICV), superior mesenteric vein (SMV), azygos vein (AV) and brain relative volume (f) assessments were carried out. Ten rats per each experimental group. Means ± SD, min/med/max, * p ˂ 0.05, at least, vs. control.